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ABSTRACT 
Objective: In this study, xanthan gum was oxidized by sodium periodate to form xanthan dialdehyde. This oxidized gum was used as crosslinking 
agent as an alternative to somewhat toxic glutaraldehyde, the basis of which is the reaction between the Schiff reagent and the aldehydes formed by 
periodate oxidation. 
Methods: Formation of aldehyde groups were confirmed by Fourier Transform Infrared Spectroscopy (FTIR). Microparticles of metoprolol 
succinate were fabricated using crosslinking of a chitosan/gelatin mix system by dialdehyde Xanthan gum. The properties of the developed 
microparticles were investigated with swelling equilibrium studies, differential scanning calorimeter (DSC), in vitro drug release studies and 
scanning electron microscopy (SEM).  
Results: The in vitro drug release from these microparticles was affected by total polymer amount, oxidation reaction time and chitosan to gelatin 
ratio. The cumulative percent release of metoprolol succinate was observed within the range of 46 to 95% at 8 h from different formulations 
studied. The factors identified as significant to produce any impact on drug loading as well as drug release were both the polymer and inter actions 
of polymer and Xanthan gum dialdehyde. 
Conclusion: The release mechanism followed the super case II model kinetics. 
Keywords: Xanthan gum Dialdehyde, Periodate oxidation, Schiff’s reagent, Chitosan, Gelatin 




Scientists throughout the world are engaged in developing biopolymer 
based biodegradable drug delivery system for various purposes like 
targeted drug delivery system, controlled release drug delivery 
systems, chronotherapeutic drug delivery systems etc due to non toxic 
nature of biomaterials, their biocompatibility, low cost and easily 
modifiable chemically to develop desired polymer [1, 2]. Gelatin is 
widely studied for drug delivery applications because of its low cost, 
renewability and biodegradability. But in aqueous environments 
gelatin is rapidly solubilized to produce fast drug release and low 
mechanical stability [3]. To overcome this disadvantage several 
researchers cross linked gelatin molecules by treating with di-or 
polyaldehydes to develop less or non-soluble products which can 
prevent the release of the drug from the matrices [4]. However, the 
presence of these residual cross-linking agents may cause toxic side 
effects. So the uses of ‘natural’ cross-linking agents, such as periodate 
oxidized gums [5] have been studied for the formation of gelatin 
devices for several purposes whose aldehyde groups can crosslink 
with 3-amino groups of lysine or hydroxylysine side groups of protein 
by Schiff’s base formation [6]. On the other hand chitosan [Poly (1,4-β-
D-glucopyranosamine)], N-deacetylated polysaccharide from chitin, 
also has an amino group in its monomer unit. Cross-linked Chitosan 
micro or nanoparticles are widely studied for targeted or controlled 
drug delivery [7]. It can also react with oxidized gum by Schiff’s base 
formation. It was postulated that dialdehyde polysaccharides. In the 
presence of sodium periodate, the oxidation of xanthan gum is 
characterized by the specific cleavage of C2-C3 bond of residues, 
resulting in the formation of aldehyde groups.  
So we have hypothesized that when a mixture of gelatin and chitosan 
would react with the xanthan dialdehyde that will result crosslinking 
of both the polymer chain. This will cause entanglement of polymer 
chains to result Interpenetrating Polymer Network (IPN), which is a 
blend of two or more polymers in a network with at least one of the 
systems synthesized in the presence of another [8]. This produces a 
formation of physically cross-linked network when polymer chains of 
the second system are entangled with or penetrate the network 
formed by the first polymer. Each individual network retains its 
individual properties so synergistic improvements in properties like 
strength or toughness can be seen [9]. Literature survey suggested 
that IPN based microparticles of metoprolol succinate using non-toxic 
xanthan gum dialdehyde as crosslinker for both chitosan and gelatin 
was not studied till date. This is the novelty of the formulation. So, the 
main objective of this study was to develop microparticles of 
metoprolol succinate using a chitosan/gelatin IPN material by 
crosslinking with dialdehyde Xanthan. The properties of the 
microparticles were investigated with Fourier Transform Infrared 
Spectroscopy (FTIR), equilibrium swelling studies, differential 
scanning calorimeter (DSC), X‑ ray diffraction (XRD) analysis, in vitro 
drug release studies, and scanning electron microscopy (SEM). 
MATERIALS AND METHODS 
Materials 
Metoprolol succinate was generously gifted by IPCA Laboratories 
Limited, Mumbai. Chitosan was purchased from Everest Biotech, 
Bangalore. The degree of deacetylation is>85%. Xanthan gum, 
pentasodium tripolyphosphate (TPP), acetic acid, isopropyl alcohol, 
propylene glycol and gelatin were purchased from Hi media. Sodium 
periodate was purchased from Loba Chemicals. All other reagents 
used are of analytical grade. In all purposes all glass double distilled 
water was used. 
Preparation of oxidized xanthan gum 
Oxidized xanthan gum was prepared as reported in the literature 
with little modifications [10]. About 1.0 g xanthan gum was 
dissolved in 20 ml distilled water. Then, 10 ml sodium periodate 
solution of 0.1g/ml was added to the xanthan gum solution under 
stirring. The pH was adjusted to 5.0 with 1 M sulfuric acid solution. 
After that the mixture was kept in the dark at 40 °C for 6 h and 24 h 
with stirring, the prepared oxidized xanthan gum was precipitated 
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by pouring the solution into a large amount of ethanol. The 
precipitate was then recovered and repeatedly washed with distilled 
water and ethanol until all iodic compounds were removed. The 
product was dried at 50 °C to constant weight for the subsequent 
use. The obtained oxidized xanthan gum was named XDA1 and XDA2 
for 6 h and 24 h incubation respectively. 
Determination of aldehyde content 
The degree of oxidation was evaluated by titration method using 
hydroxylamine hydrochloride as elaborated in literature [11]. In 
brief, an excess of hydroxylamine hydrochloride was reacted with 
oxidized xanthan gum that formed hydrochloric acid. It was then 
titrated with NaOH and aldehyde content in oxidized xanthan gum 
was calculated from it. The same concentration of xanthan gum 
solution at pH 5 was used as a blank and its consumption of the 
alkali solution in liter was recorded.  
The degree of oxidation was calculated according to the following 
equation where Va is the consumed volume of NaOH solution (0.1 M) 
at the equivalence point, n is the possible number of aldehyde 
groups, m is the dry weight of oxidized XG and 934 g/mol is the 
molecular weight of the repeating unit of XG. In the case of xanthan 
gum, eight aldehyde groups can be formed per repeating unit by the 
cleavage of the C–C bond between adjacent–CHOH groups. 
 
Preparation of microparticles of chitosan gelatin cross-linked 
with xanthan dialdehyde. 
Gelatin solution (10%, w/v) was prepared by soaking gelatin powder 
in distilled water for 30 min and then heated at 60 °C for 30 min under 
continuous stirring. Chitosan 1%w/v solution was prepared in dilute 
acetic acid solution. Both the Chitosan and gelatin solutions were 
mixed and the pH was raised to 5. Oxidized xanthan gum solution 
(10%, w/v) was prepared in borax solution and pH was adjusted to 9. 
The resulting Chitosan and gelatin mixture was added dropwise with 
the help of a syringe to the oxidized xanthan gum solution at 40 °C 
with stirring for 2 h to obtain microparticles. Then this microparticles 
were again incubated in 1%w/v TPP solution for 2 h. 
Experimental design 
A full factorial 24-design was employed to study the effect of 
independent variables. Optimization of the formulation development 
process was performed using statistical experimental design with a 
software DESIGN EXPERT® version 7.0.2.8 (Stat-Ease Inc., 
Minneapolis, USA)[12]. Response surface diagrams were used to show 
the factor interaction between the independent considered variables. 
Selected independent variables studied were the amount of total 
polymer(X1), % of 2nd polymer i.e. gelatin(X2), Oxidation reaction time 
(X3) and amount of drug (X4). Two factorial levels coded for low, and 
high settings (−1 and +1, respectively) were considered for four 
independent variables. The selected dependent variables investigated 
were the Entrapment Efficiency value (Y1), and cumulative percent 
release (CPR) at 8 h (Y2) Formulations F1-F16 were prepared by 
varying the levels of the independent variables as required by the 
experimental design and factors levels along with the results of 
dependent variables were mentioned in table 1. 
Swelling study 
The progress of water sorption in the microsphere was determined 
by the help of swelling study. The swelling characteristics of 
microsphere were determined by immersing dried microsphere in 
different buffer solution until equilibrium is achieved. A 10 mg of 
microsphere was taken in a beaker containing 10 ml different 
solutions [pH1.2 buffer solution and phosphate buffer solution of pH 
6.8] for 8 h at 37 °C. At specific time intervals, the samples were 
removed from the swelling medium and were blotted with a piece of 
paper to absorb excess water on the surfaces. The swelling ratios 
(Qs) of test samples were calculated from the following expression:  
Qs=  
Where Ws is the weight of the swollen test sample and Wd is the 
weight of the dried test sample. 
In vitro release study  
In vitro release study was carried out by using a type 1 dissolution test 
apparatus. In brief, 20 mg of microsphere was accurately weighed and 
placed in 500 ml phosphate buffer of pH 6.8 {SIF) in the dissolution 
flask at a temperature of 37 °C±0.5 °C with 50 rpm stirring speed of 
the paddle. At a particular time interval 5 ml sample was withdrawn 
and replenish with fresh buffer solution. The aliquots samples were 
analyzed using double beam spectrophotometer at 276 nm. 
Kinetic analysis of release data of tablets  
Different model equations were used to analyze the in vitro 
dissolution data of metoprolol release from the microparticles and 
to study the release mechanism. It has been observed that the 
release rates follow zero-order, Weibull and the Korsmeyer and 
Peppas equation. The software KinetDS3.0 was used to study the 
model fitting. The n value of the Korsmeyer and Peppas equation is 
an exponent used to characterize the transport mechanism. Here we 
obtained n value>0.89 that suggests for Super Case II transport. Case 
II relaxation release is the drug transport mechanism associated 
with stresses and state-transition in hydrophilic glassy polymers, 
which swell in water or biological fluids. Case II generally refers to 
erosion of polymeric chain and anomalous transport (non-fickian) 
refers to a combination of both diffusion and erosion controlled drug 
release. 
RESULTS AND DISCUSSION 
Preparation of microsphere 
In present investigation, native xanthan gum was oxidized with 
sodium periodate at room temperature. It had been assumed that 
hydroxyl group on carbon 2 and 3 of the repetitive unit were 
oxidized by sodium periodate which caused rupturing of carbon-
carbon bond to the formation of two aldehyde group in each 
oxidized monomeric unit. This oxidized xanthan was subsequently 
cross-linked with chitosan and gelatin to form drug loaded 
microsphere by ionotropic gelation method in completely aqueous 
environment. In this present study borax is also used. Gelatin 
increased the rigidity of the structure and also increased the 
swelling property, drug entrapment efficiency and drug release rate. 
As it is Schiff base reaction borax is used for higher pH reaction. 
Borax also increases the spherical shape of the microsphere. A full 
factorial 24-design was employed to develop optimized formulatin. 
The effects of different variables are recorded in table 1. 
FT-IR analysis 
The FT-IR spectra of xanthan gum and xanthan gum dialdehyde 
were compared and it was represented in fig. 1a and b. FT-IR 
spectrum of xanthan gum showed absorption band at 1604.77 cm-1 
and 1411.89 cm-1 was assigned to asymmetric stretching and 
symmetric stretching peak of the carboxylate salt group. The 
presence of aldehydes group was confirmed by C=O stretching band 
at 1724.30 cm-1. 
Drug entrapment efficiency 
The drug percent entrapment efficacy of nanoparticles was achieved 
between 94.36%-52.74%. Drug entrapment was found more in the 
formulation having greater polymer concentration and found less in 
the formulation having less polymer concentration. This is due to the 
increased availability of the polymer for encapsulating the drug. The 
presence of gelatin also increases drug entrapment efficiency. 
Response surface diagram (fig. 3) clearly indicates that total polymer 
and presence of gelatin influence drug entrapment efficiency. 
Experimental design 
The present study consisted of a two-level full-factorial Design for 
four factors (24) for experimentation. Optimization of the 
formulation development process was performed using statistical 
experimental design with a software DESIGN EXPERT® version 
7.0.2.8 (Stat-Ease Inc., Minneapolis, USA). Response surface 
diagrams (fig. 3) were used to show the factor interaction between 
the independent considered variables. Two factorial levels coded for 
low, and high settings (−1 and+1, respectively) were considered for 
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four independent variables. The selected dependent variables 
investigated were the Drug Entrapment Efficicency value (Y1), and 
CPR at 8 h (Y2). A total of 16 experimental runs were required for 
analyzing the interaction of each level on formulation characters and 
to optimize. Table 1 shows the factors were chosen and different 
factor level settings. The response in each trial was measured by 
carrying out a multiple factorial regression analysis using the 
quadratic model: 
 






(% of X1) (X2) 
Oxidation reaction 







F1 200 30 24 100 94.94±2.43 81.82±2.12 
F2 100 30 24 100 59.89±3.71 94.76±2.45 
F3 200 0 24 100 79.43±1.76 76.34±2.18 
F4 100 0 24 100 56.51±2.92 83.17±1.89 
F5 200 30 6 100 92.36±1.34 73.44±1.57 
F6 100 30 6 100 62.00±2.03 92.00±1.05 
F7 200 0 6 100 80.42±1.89 68.23±1.87 
F8 100 0 6 100 59.11±1.46 92.23±2.07 
F9 200 30 24 50 87.67±2.12 46.61±1.83 
F10 100 30 24 50 67.32±1.85 90.65±2.09 
F11 200 0 24 50 80.22±3.12 62.41±0.64 
F12 100 0 24 50 52.63±1.09 83.71±1.58 
F13 200 30 6 50 90.7±1.67 76.56±1.58 
F14 100 30 6 50 64.42±2.23 95.22±2.45 
F15 200 0 6 50 81.64±2.91 72.41±1.73 
F16 100 0 6 50 58.16±0.78 86.32±2.32 
DEE= Drug Entrapment Efficiency, CPR= Cumulative Percent Release, all values are expressed as mean±SD, #n=3 *n=3 
 
  
a.      b. 
Fig. 1: FTIR spectra of xanthan gum (a) and its dialdehyde (b) 
 
Table 2: ANOVA study result 
A. ANOVA study result for a selected factorial model for the response Y2(CPR at 8 h) 
Source Sum of Squares df Mean square F-value p-value  
Model 2676.31 11 243.30 29.43 0.0026 significant 
X1-Total amt polymer 1683.05 1 1683.05 203.56 0.0001  
X2-amt Gelatin 56.63 1 56.63 6.85 0.0590  
X3-oxidation reaction time 68.39 1 68.39 8.27 0.0452  
X4-drug amt 122.32 1 122.32 14.79 0.0184  
X1*X2 64.08 1 64.08 7.75 0.0496  
X1*X4 97.22 1 97.22 11.76 0.0266  
X3*X4 178.62 1 178.62 21.60 0.0097  
X1*X2*X3 69.72 1 69.72 8.43 0.0439  
X1*X2*X4 58.83 1 58.83 7.12 0.0560  
X1*X3*X4 220.67 1 220.67 26.69 0.0067  
X2*X3*X4 56.78 1 56.78 6.87 0.0588  
Residual 33.07 4 8.27    
Cor Total 2709.39 15     
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B. ANOVA study result for a selected factorial model for the response Y2(CPR at 8 h) 
Source Sum of squares df Mean square F-value p-value  
Model 3103.34 13 238.72 146.76 0.0068 significant 
A-Total amt polymer 2686.87 1 2686.87 1651.82 0.0006  
B-amt Gelatin 316.66 1 316.66 194.68 0.0051  
C-cross linking time 6.50 1 6.50 4.00 0.1836  
AB 17.51 1 17.51 10.77 0.0817  
AC 1.25 1 1.25 0.7712 0.4725  
AD 8.91 1 8.91 5.48 0.1441  
BC 7.40 1 7.40 4.55 0.1666  
BD 0.8742 1 0.8742 0.5375 0.5398  
CD 0.9801 1 0.9801 0.6025 0.5188  
ABD 41.02 1 41.02 25.22 0.0374  
ACD 4.12 1 4.12 2.53 0.2524  
BCD 0.4761 1 0.4761 0.2927 0.6427  
ABCD 10.76 1 10.76 6.61 0.1237  
Residual 3.25 2 1.63    
Cor Total 3106.60 15     
 
Analysis of variance (ANOVA) was applied for the estimation of the 
significance of the model. Using a 5% significance level, a model was 
considered significant if the p<0.05. It was found that after removal 
of some insignificant factors for responses both Y1 and Y2 the linear 
contribution model were significant (p<0.001). Table 2 shows the 
factor effects of the quadratic model and associated p values for all 
five responses. The Model F-value of 29.43 implies the model is 
significant. There is only a 0.77% chance that a "Model F-value" this 
large could occur due to noise. Values of "Prob>F" less than 0.0500 
indicate model terms are significant. In this case X1, X3, X4, X1*X2, 
X1*X4, X3*X4, X1*X2*X3 and X1*X3*X4 are significant model terms.  
Fig. 2 shows the pareto chart of t-value of effect vs rank for the 
factor Y2. It also indicates that X1, X3, X4, X1*X2, X1*X4, X3*X4, 
X1*X2*X3 and X1*X3*X4 are significant model terms because the 
t=value of these single factors and interaction effects are lying 
between Bonferroni Limit 6.25407 t-Value Limit 2.77645. 
  
  
Fig. 2: Pareo chart of t-value of effect vs rank for the factor Y1(A) and Y2 (B) 
 
Final equation in terms of coded factors 
For response CPR at 8 H 
CPR at 8 h (Y2) = +79.98+10.26*X1+1.88*X2-2.07*X3 +2.88*X4-
2.0*X1*X2 +2.47*X1*X4+3.34*X3*X4 – 2.09*X1*X2*X3 + 
1.92*X1*X2*X4 + 3.71*X1*X3*X4  ……………………. (1) 
For response drug entrapment efficiency (%) 
DEE (Y1) = +72.96 +12.96*X1+ 4.45*X2 -
0.64*X3+1.05*X1*X2+0.74*X1*X4+0.68*X2*X3 - 0.23*X2*X4 + 
0.25*X3*X4 +1.60*X1*X2*X4+0.51*X1*X3*X4+0.82*X1*X2*X3*X4 … 
(2) 
Estimation of quantitative effects of factors 
A factor was considered to influence the response if the effects are 
significant (p<0.05). A positive value indicates a synergistic effect 
that favors optimization, while a negative sign represents an 
antagonistic effect or inverse effect of the factor on the selected 
response [13]. When we study the optimization of formulation for 
100 mg constant drug amount considering 70% CPR at 8 h and 
100% Drug Entrapment Efficiency it was observed that 200 mg total 
polymer, 30% gelatin wrt total polymer and 6 h oxidation reaction 
time is the predicted optimized formula for around 91% DEE and 
72%CPR at 8 h. This prediction matches with the formulation No. F5. 
It is shown in an equation that response Y1 (CPR at 8 h) was 
significantly influenced by the synergistic effect of total polymer 
concentration (A). For second response Y2 (percentage entrapment 
efficiency), the significant factors were identified as both the 
polymer and interactions of polymer and Xanthan gum dialdehyde. 
DSC analysis 
DSC thermogram of Xanthan dialdehyde cross-linked blank bead, 
drug-loaded bead and the drug metoprolol are displayed in fig.  
Thermogram of the pure drug shows a sharp endothermic peak at 
145 °C indicating its melting point. Drug formulation does not show 
any peak means that drug is in amorphous state in the formulation. 
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Fig. 3: Response surface diagram for the effect total polymer amount and presence of gelatin on CPR at 8 h (a) and DEE(b) 
 
 
Fig. 4: DSC analysis of drug, drug loaded formulation and blank formulations 
 
 
Fig. 5: SEM analysis of drug-loaded formulation 
 
SEM analysis 
SEM of microspheres was taken at high magnifications. The 
formulations were all hemispherical. The surfaces were not very 
smooth and present in a compact form and drug crystal are not 
visible in the surface. 
Swelling study 
Here swelling study is done in two different swelling medium i.e. 0.1 
(N) HCl of pH 1.2 and phosphate buffer solution of pH 6.8. The data of 
swelling ratio in pH 1.2 and pH 6.8 were presented in table. The data 
show that the microspheres have a more swelling ratio in pH 1.2 from 
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79.90%-51.37% than in pH 6.8 from 32.94%-22.10%. The amount of 
polymer concentration has a great effect on swelling ratio as well as in 
drug entrapment and release rates of drug. As the polymer 
concentration is increased swelling ratio is also increased due to more 
water entrapment. The presence of gelatin also increases the swelling 
ratio. The oxidation reaction time for formation of cross-linker has 
also affected the swelling ratio. When XDA2 in the matrice increases, 
the percent equilibrium water uptake significantly decreases. This is 
mainly due to increased crosslink density and decreased pore volume 
of the polymeric network with increasing aldehyde group in the 
oxidized xanthan in the matrix. But the presence of gelatin 
significantly increases the swelling ratio amongst all the factors. 
 
 
Fig. 6: Comparison of swelling ratio at 4h of all the formulations at different pH, all values are expressed as mean±SD, n=3 
 
In vitro drug release study 
In vitro drug release study data show that an increase in polymer 
concentration and presence of gelatin produce positive impact but the 
oxidation reaction time has a negative effect on drug release. It is 
observed from the result that F3, F5. F7. F13 and F15 have CPR at 8h 
within 68 to 76%. But among them F5 formulation matches both the 
requirements of DEE and CPR. In all the cases total polymer amount is 
maximum. That indicates total poly concentration plays major role for 
development of the formulation. F2, F6, F8 and F14 have shown more 
than 90% release at 8h. In all the cases total polymer amount is 100 mg. 
It may be due low retardation effect exerted by total polymer system. 
 
 
Fig. 7: Comparison of In-vitro dissolution rate study of Formulation F1 to F8(A) and F9 to F16 (B) at pH 6.8 buffer, *All results were plotted 
as mean±SD, n=3 
 
Determination of the release kinetics 
Release kinetics of micro-particles were evaluated with various 
models using KinetDS3.0 software and it was observed that all the 
formulations followed the emperical model that follow dissolution 
based mechanism such as Zero-order, Korsmeyer-Peppas model, 
Weibull equation and Hill equation. By using Korsmeyer and Peppas 
equation, the n values were obtained more than 1 (table 3) for all 
formulations. These values are characteristic of super case–II 
transport, suggesting that more than one mechanism may be 
involved in release kinetics. The mechanism of drug release can be 
described by the phenomenon that involves the disentanglement 
and erosion of the polymer. The release process involves the 
penetration of water into dry matrix followed by hydration and 
swelling of the polymer, and diffusion of the drug dissolved in the 
matrix [14]. For all the formulations, the contribution of polymer 
relaxation occurs throughout the entire dissolution time period. This 
was also apparent from the n values obtained (table 3), which 
approaches super case-II [15} transport. In general, the relaxation 
contribution was higher for the formulations with higher n values. 
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Table 3: Kinetic model analysis of the release of metoprolol from microparticles 
Formulation Zero-order Korsmeyer pappas Weibull DE (%) MDT(h) 
r r n r 
F1 0.98 0.99 1.098 0.99 43.58 3.74 
F2 0.91 0.99 1.08 0.99 34.01 5.12 
F3 0.94 0.99 1.09 0.99 43.96 3.39 
F4 0.94 0.99 1.10 0.99 50.74 3.11 
F5 0.96 0.99 1.09 0.99 39.84 3.66 
F6 0.978 0.99 1.10 0.99 51.5 3.66 
F7 0.91 0.99 1.09 0.99 38.39 3.5 
F8 0.99 0.99 1.10 0.99 48.5 3.8 
F9 0.96 0.99 1.07 0.99 26.99 3.36 
F10 0.97 0.99 1.10 0.99 49.57 3.6 
F11 0.95 0.99 1.08 0.99 34.11 3.6 
F12 0.99 0.99 1.10 0.99 46.59 3.5 
F13 0.96 0.99 1.09 0.99 43.7 3.4 
F14 0.95 0.98 1.08 0.99 34.1 5.14 
F15 0.96 0.99 1.09 0.99 42.56 3.41 
F16 0.94 0.99 1.10 0.99 48.12 3.71 
 
CONCLUSION 
In this study, xanthan gum was successfully oxidized to form 
dialdehyde. Microparticles of Chitosan-gelatin polymer combined 
matrices containing metoprolol succinate were successfully 
prepared using xanthan gum dialdehyde as crosslinker. The drug 
release from these polymer systems was studied and it was 
observed that total polymer amount and chitosan to gelatin ratio 
influenced the release rate maximum. The release kinetics followed 
the super case II model.  
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